Ketamine, Psychedelics, and Neuroplasticity: Experts Weigh In

Learn more about the link between neuroplasticity, psychedelics, and mental health from two experts in our recent webinar.

Wondermed and Neuly webinar on neuroplasticity & psychedelics with Lauren Swanson, Taylor Kuhn, and moderator Matt Zemon

Neuroplasticity is an incredibly powerful concept in the field of mental health. It refers to the brain’s innate ability to change by forming new neural connections and reshaping existing ones.

Neuroplasticity is thought to play a key role in the therapeutic effects of psychedelics for mental health conditions like depression and anxiety. By enhancing neuroplasticity in the brain, drugs like psilocybin and ketamine make it easier to break out of negative patterns of thought and behavior and adopt healthier, more positive ones.

In our recent webinar with Neuly, we explored the concept of neuroplasticity and the role it plays in the emerging space of psychedelic-assisted therapy. 

Leading the discussion was Wondermed’s Director of Patient Care, Lauren Swanson, PA, alongside Taylor Kuhn, PhD, an Assistant Research Neuroscientist in the Department of Psychiatry and Biobehavioral Sciences at UCLA. Matt Zemon, author of two best-selling books on the therapeutic use of psychedelics, moderated the panel.

Topics covered included:

  • What happens in the brain when someone takes psychedelics
  • How to take advantage of the window of increased neuroplasticity induced by psychedelics for healing
  • How different psychedelics affect the brain and the implications for treating different mental health conditions
  • The applications of ketamine, how to access it, how it’s administered, and other considerations for therapeutic use
  • The dangers and risks of psychedelics and strategies to mitigate harm and ensure safety

Want to hear more? Watch the full recording here.


Ready to embark on your own healing journey with Wondermed?

Get Started

Want to learn more about at-home ketamine therapy?